|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Musculoskeletal Imaging |
1 From the Departments of Diagnostic Radiology and Organ Imaging (J.F.G., G.E.A., J.K.T.W., A.T.A.), Orthopaedics and Traumatology (S.M.K., K.H.C., K.M.C., P.C.L.,), Medicine (D.S.C.H., A.K.L.W.), Anaesthesia and Intensive Care (G.M.J.), and Centre for Epidemiology and Biostatistics (A.Y.K.C.), Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong. Received January 19, 2004; revision requested March 19; final revision received June 30; accepted July 26. Address correspondence to J.F.G. (e-mail: griffith@ruby.med.cuhk.edu.hk).
PURPOSE: To evaluate whether there is a relationship between steroid treatment and risk for osteonecrosis of the hip and knee in patients with severe acute respiratory syndrome (SARS).
MATERIALS AND METHODS: The hospital ethics committee approved the study, and all patients provided written informed consent. A total of 254 patients with confirmed SARS treated with steroids underwent evaluation with magnetic resonance (MR) imaging for osteonecrosis. Clinical profiles, joint symptoms, relevant past medical and drug history, steroid dose, and radiographic and MR imaging evidence of osteonecrosis and other bone abnormalities were evaluated. Mann-Whitney, Kruskal-Wallis, and Pearson exact
2 tests were performed, and univariate and multivariate logistic regression analyses were applied.
RESULTS: One hundred thirty-four (53%) of 254 patients had recent onset of large joint pain, but 211 (80%) of 264 painful joints were not associated with abnormality on MR images. MR images in 12 (5%) of 254 patients showed evidence of subchondral osteonecrosis in the proximal femur (n = 9), distal femur (n = 2), and proximal and distal femora and proximal tibiae (n = 1). Additional nonspecific subchondral and intramedullary bone marrow abnormalities were present in 77 (30%) of 254 patients. Results of multiple logistic regression analysis confirmed cumulative prednisolone-equivalent dose to be the most important risk factor for osteonecrosis. The risk of osteonecrosis was 0.6% for patients receiving less than 3 g and 13% for patients receiving more than 3 g prednisolone-equivalent dose. No relationship was found between additional nonspecific bone marrow abnormalities and steroid dose.
CONCLUSION: An appreciable dose-related risk was found for osteonecrosis in patients receiving steroid therapy for SARS. Additional nonspecific bone marrow abnormalities were frequent. Joint pain was common after SARS infection and was not a useful clinical indicator of osteonecrosis.
© RSNA, 2005
This article has been cited by other articles:
![]() |
N.-F. Zhang, Z. R. Li, H.-Y. Wei, Z.-H. Liu, and P. Hernigou Steroid-induced osteonecrosis: THE NUMBER OF LESIONS IS RELATED TO THE DOSAGE J Bone Joint Surg Br, September 1, 2008; 90-B(9): 1239 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. C. Wong and W. S. Poon Risk of High Dose Hydrocortisone in Patients With Aneurysmal Subarachnoid Hemorrhage Stroke, January 1, 2008; 39(1): e12 - e12. [Full Text] [PDF] |
||||
![]() |
V. C. C. Cheng, S. K. P. Lau, P. C. Y. Woo, and K. Y. Yuen Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection Clin. Microbiol. Rev., October 1, 2007; 20(4): 660 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-c. Chen, X.-p. Tang, S.-y. Tan, B.-l. Liang, Z.-y. Wan, J.-q. Fang, and N. Zhong Treatment of Severe Acute Respiratory Syndrome With Glucosteroids: The Guangzhou Experience Chest, June 1, 2006; 129(6): 1441 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mont, L. C. Jones, and D. S. Hungerford Nontraumatic Osteonecrosis of the Femoral Head: Ten Years Later J. Bone Joint Surg. Am., May 1, 2006; 88(5): 1117 - 1132. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |